Brain and Spinal MR Imaging Findings in Mucopolysaccharidoses: A Review

References

1. 1.↵
   1. Scriver CR,
   2. Beaudet AL,
   3. Sly WS

   1. Neufeld EF,
   2. Muenzer J

   . The Mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001;3421–52
2. 2.↵
   1. Clarke LA

   . The mucopolysaccharidoses: a success of molecular medicine. Expert Rev Mol Med 2008;10:e1

   CrossRefPubMed
3. 3.↵
   1. Gilles FH,
   2. Deuel RK

   . Neuronal cytoplasmic globules in the brain in Morquio's syndrome. Arch Neurol 1971;25:393–403

   CrossRefPubMed
4. 4.↵
   1. Muenzer J

   . The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr 2004;144:27–34

   CrossRef
5. 5.↵
   1. Wraith JE

   . The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child 1995;72:263–67

   FREE Full Text
6. 6.↵
   1. Al Sawaf S,
   2. Mayatepek E,
   3. Hoffmann B

   . Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed. J Inherit Metab Dis 2008;31:473–80

   CrossRefPubMed
7. 7.↵
   1. Dekaban AS,
   2. Constantopoulos G

   . Mucopolysaccharidosis type I, II, IIIA and V: pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain. Acta Neuropathol 1977;39:1–7

   CrossRefPubMed
8. 8.↵
   1. Nelson J,
   2. Grebbell FS

   . The value of computed tomography in patients with mucopolysaccharidosis. Neuroradiology 1987;29:544–49

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Patay Z

   . Diffusion-weighted MR imaging in leukodystrophies. Eur Radiol 2005;15:2284–303

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Lee C,
    2. Dineen TE,
    3. Brack M,
    4. et al

    . The mucopolysaccharidoses: characterization by cranial MR imaging. AJNR Am J Neuroradiol 1993;14:1285–92

    Abstract/FREE Full Text
11. 11.↵
    1. Barone R,
    2. Parano E,
    3. Trifiletti RR,
    4. et al

    . White matter changes mimicking a leukodystrophy in a patient with mucopolysaccharidosis: characterization by MRI. J Neurol Sci 2002;195:171–75

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Matheus MG,
    2. Castillo M,
    3. Smith JK,
    4. et al

    . Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 2004;46:666–72

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Takahashi Y,
    2. Sukegawa K,
    3. Aoki M,
    4. et al

    . Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr Res 2001;49:349–55

    CrossRefPubMed
14. 14.↵
    1. Gabrielli O,
    2. Salvolini U,
    3. Maricotti M,
    4. et al

    . Cerebral MRI in two brothers with mucopolysaccharidosis type I and different clinical phenotypes. Neuroradiology 1992;34:313–15

    CrossRefPubMed
15. 15.↵
    1. Kulkarni MV,
    2. Williams JC,
    3. Yeakley JW,
    4. et al

    . Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses. Magn Reson Imaging 1987;5:317–23

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Taccone A,
    2. Tortori Donati P,
    3. Marzoli A,
    4. et al

    . Mucopolysaccharidosis: thickening of dura mater at the craniocervical junction and other CT/MRI findings. Pediatr Radiol 1993;23:349–52

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Rauch RA,
    2. Friloux LA 3rd.,
    3. Lott IT

    . MR imaging of cavitary lesions in the brain with Hurler/Scheie. AJNR Am J Neuroradiol 1989;10:1–3

    PubMed
18. 18.↵
    1. Seto T,
    2. Kono K,
    3. Morimoto K,
    4. et al

    . Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 2001;50:79–92

    CrossRefPubMed
19. 19.↵
    1. Gabrielli O,
    2. Polonara G,
    3. Regnicolo L,
    4. et al

    . Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am J Med Genet A 2004;125A:224–31

    PubMed
20. 20.↵
    1. Parsons VJ,
    2. Hughes DG,
    3. Wraith JE

    . Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II). Clin Radiol 1996;51:719–23

    CrossRefPubMed
21. 21.↵
    1. Murata R,
    2. Nakajima S,
    3. Tanaka A,
    4. et al

    . MR imaging of the brain in patients with mucopolysaccharidosis. AJNR Am J Neuroradiol 1989;10:1165–70

    Abstract/FREE Full Text
22. 22.↵
    1. Manara R,
    2. Priante E,
    3. Grimaldi M,
    4. et al

    . Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy. J Inherit Metab Dis 2011;34:763–80. Epub 2011 Apr 5

    CrossRefPubMed
23. 23.↵
    1. Shinomiya N,
    2. Nagayama T,
    3. Fujioka Y,
    4. et al

    . MRI in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neuroradiology 1996;38:483–85

    CrossRefPubMed
24. 24.↵
    1. Finn CT,
    2. Vedolin L,
    3. Schwartz IV,
    4. et al

    . Magnetic resonance imaging findings in Hunter syndrome. Acta Paediatr Suppl 2008;97:61–68

    CrossRefPubMed
25. 25.↵
    1. Shimoda-Matsubayashi S,
    2. Kuru Y,
    3. Sumie H,
    4. et al

    . MRI findings in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neuroradiology 1990;32:328–30

    CrossRefPubMed
26. 26.↵
    1. Vedolin L,
    2. Schwartz IV,
    3. Komlos M,
    4. et al

    . Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR Am J Neuroradiol 2007;28:1029–33

    Abstract/FREE Full Text
27. 27.↵
    1. Zafeiriou D,
    2. Auggoustidou-Savvopoulou PA,
    3. Papadopoulou FA,
    4. et al

    . Magnetic resonance imaging findings in mild mucopolysaccharidosis II (Hunter's syndrome). Eur J Paediatr Neurol 1998;2:153–56

    CrossRefPubMed
28. 28.↵
    1. Zafeiriou DI,
    2. Savvopoulou-Augoustidou PA,
    3. Sewell A,
    4. et al

    . Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B). Brain Dev 2001;23:385–89

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Ozand PT,
    2. Thompson JN,
    3. Gascon GG,
    4. et al

    . Sanfilippo type D presenting with acquired language disorder but without features of mucopolysaccharidosis. J Child Neurol 1994;9:408–11

    Abstract/FREE Full Text
30. 30.↵
    1. Thorne JA,
    2. Javadpour M,
    3. Hughes DG,
    4. et al

    . Craniovertebral abnormalities in type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 2001;48:849–52

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Büyükgebiz B,
    2. Eroğlu Y,
    3. Kovanlikaya I,
    4. et al

    . Maroteaux-Lamy syndrome associated with growth hormone deficiency. J Pediatr Endocrinol Metab 1995;8:305–07

    PubMed
32. 32.↵
    1. Johnson MA,
    2. Desai S,
    3. Hugh-Jones K,
    4. et al

    . Magnetic resonance imaging of the brain in Hurler syndrome. AJNR Am J Neuroradiol 1984;5:816–19

    FREE Full Text
33. 33.↵
    1. Walkley SU,
    2. Thrall MA,
    3. Haskings ME,
    4. et al

    . Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease. Neuropathol Appl Neurobiol 2005;31:536–44

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Kwee RM,
    2. Kwee TC

    . Virchow-Robin spaces at MR imaging. Radiographics 2007;27:1071–86

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Groeschel S,
    2. Chong WK,
    3. Surtees R,
    4. et al

    . Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature. Neuroradiology 2006;48:745–54

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Valayannopoulos V,
    2. Boddaert N,
    3. Barbier V,
    4. et al

    . Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase. Mol Genet Metab 2010;100:20–23

    CrossRefPubMed
37. 37.↵
    1. Fan Z,
    2. Styner M,
    3. Muenzer J,
    4. et al

    . Correlation of automated volumetric analysis of brain MR imaging with cognitive impairment in a natural history study of mucopolysaccharidosis II. AJNR Am J Neuroradiol 2010;31:1319–23

    Abstract/FREE Full Text
38. 38.↵
    1. Kara S,
    2. Sherr EH,
    3. Barkovich AJ

    . Dilated perivascular spaces: an informative radiologic finding in Sanfilippo syndrome type A. Pediatr Neurol 2008;38:363–66

    CrossRefPubMed
39. 39.↵
    1. Miyazaki T,
    2. Masuda N,
    3. Waragai M,
    4. et al

    . An adult Japanese Sanfilippo A patient with novel compound heterozygous S347F and D444G mutations in the sulphamidase gene. J Neurol Neurosurg Psychiatry 2002;73:777–78

    FREE Full Text
40. 40.↵
    1. Verhoeven WM,
    2. Csepán R,
    3. Marcelis CL,
    4. et al

    . Sanfilippo B in an elderly female psychiatric patient: a rare but relevant diagnosis in presenile dementia. Acta Psychiatr Scand 2010;122:162–65

    CrossRefPubMed
41. 41.↵
    1. Barone R,
    2. Nigro F,
    3. Triulzi F,
    4. et al

    . Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics 1999;30:270–74

    PubMedWeb of Science
42. 42.↵
    1. Lücke T,
    2. Das AM,
    3. Hartmann H,
    4. et al

    . Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study. Dev Med Child Neurol 2007;49:693–96

    CrossRefPubMed
43. 43.↵
    1. Stöckler S,
    2. Kleinert R,
    3. Ebner F,
    4. et al

    . Mucopolysaccharidosis I and intracranial tumor in a patient with high-pressure hydrocephalus. Pediatr Radiol 1993;23:353–54

    CrossRefPubMed
44. 44.↵
    1. Vougioukas VI,
    2. Berlis A,
    3. Kopp MV,
    4. et al

    . Neurosurgical interventions in children with Maroteaux-Lamy syndrome: case report and review of the literature. Pediatr Neurosurg 2001;35:35–38

    CrossRefPubMed
45. 45.↵
    1. Concolino D,
    2. Muzzi G,
    3. Pisaturo L,
    4. et al

    . Precocious puberty in Sanfilippo IIIA disease: diagnosis and follow-up of two new cases. Eur J Med Genet 2008;51:466–71

    CrossRefPubMed
46. 46.↵
    1. Ohmi K,
    2. Greenberg DS,
    3. Rajavel KS,
    4. et al

    . Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A 2003;100:1902–07

    Abstract/FREE Full Text
47. 47.↵
    1. Ferrer I,
    2. Cusi V,
    3. Pineda M,
    4. et al

    . Focal dendritic swellings in Purkinje cells in mucopolysaccharidoses types I, II and III: a Golgi and ultrastructural study. Neuropathol Appl Neurobiol 1988;14:315–23

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Robertson SJ,
    2. Wolpert SM,
    3. Runge VM

    . MR imaging of middle cranial fossa arachnoid cysts: temporal lobe agenesis syndrome revisited. AJNR Am J Neuroradiol 1989;10:1007–10

    Abstract/FREE Full Text
49. 49.↵
    1. Santamarta D,
    2. Aguas J,
    3. Ferrer E

    . The natural history of arachnoid cysts: endoscopic and cine-mode MRI evidence of a slit-valve mechanism. Minim Invasive Neurosurg 1995;38:133–37

    CrossRefPubMedWeb of Science
50. 50.↵
    1. Ebara S,
    2. Kinoshita T,
    3. Yuzawa Y,
    4. et al

    . A case of mucopolysaccharidosis IV with lower leg paresis due to thoraco-lumbar kyphoscoliosis. J Clin Neurosci 2003;10:358–61

    CrossRefPubMed
51. 51.↵
    1. Wilson S,
    2. Hashamiyan S,
    3. Clarke L,
    4. et al

    . Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities. Am J Pathol 2009;175:2053–62

    CrossRefPubMedWeb of Science
52. 52.↵
    1. Aydin M,
    2. Akarsu S,
    3. Kabakus N,
    4. et al

    . Mucopolysaccharidosis IIIB, cerebral vasculopathy and recurrent subdural hematoma. Indian Pediatr 2006;43:437–40

    PubMed
53. 53.↵
    1. Chan JW

    . Pseudotumor cerebri in Morquio type IV syndrome. J Child Neurol 2009;24:514–15

    FREE Full Text
54. 54.↵
    1. Hughes DG,
    2. Chadderton RD,
    3. Cowie RA,
    4. et al

    . MRI of the brain and craniocervical junction in Morquio's disease. Neuroradiology 1997;39:381–85

    CrossRefPubMedWeb of Science
55. 55.↵
    1. Vinchon M,
    2. Cotten A,
    3. Clarisse J,
    4. et al

    . Cervical myelopathy secondary to Hunter syndrome in an adult. AJNR Am J Neuroradiol 1995;16:1402–03

    Abstract
56. 56.↵
    1. Giussani C,
    2. Roux FE,
    3. Guerra P,
    4. et al

    . Severely symptomatic craniovertebral junction abnormalities in children: long-term reliability of aggressive management. Pediatr Neurosurg 2009;45:29–36

    CrossRefPubMed
57. 57.↵
    1. Piccirilli CB,
    2. Chadduck WM

    . Cervical kyphotic myelopathy in a child with Morquio syndrome. Childs Nerv Syst 1996;12:114–16

    CrossRefPubMed
58. 58.↵
    1. Tandon V,
    2. Williamson JB,
    3. Cowie RA,
    4. et al

    . Spinal problems in mucopolysaccharidosis I (Hurler syndrome). J Bone Joint Surg Br 1996;78:938–44

    CrossRefPubMed
59. 59.↵
    1. Kachur E,
    2. Del Maestro R

    . Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 2000;47:223–28

    CrossRefPubMedWeb of Science
60. 60.↵
    1. Miebach E,
    2. Church H,
    3. Cooper A,
    4. et al

    . The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome). J Inherit Metab Dis 2011;34:755–61. Epub 2011 Mar 17

    CrossRefPubMed
61. 61.↵
    1. O'Brien DP,
    2. Cowie RA,
    3. Wraith JE

    . Cervical decompression in mild mucopolysaccharidosis type II (Hunter syndrome). Childs Nerv Syst 1997;13:87–90

    CrossRefPubMedWeb of Science
62. 62.↵
    1. Dickerman RD,
    2. Colle KO,
    3. Bruno CA Jr.,
    4. et al

    . Craniovertebral instability with spinal cord compression in a 17-month-old boy with Sly syndrome (mucopolysaccharidosis type VII): a surgical dilemma. Spine (Phila Pa 1976) 2004;29:92–94

    CrossRef
63. 63.↵
    1. Mut M,
    2. Cila A,
    3. Varli K,
    4. et al

    . Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature. Clin Neurol Neurosurg 2005;107:230–35

    CrossRefPubMedWeb of Science
64. 64.↵
    1. Pizzutillo PD,
    2. Osterkamp JA,
    3. Scott CI Jr.,
    4. et al

    . Atlantoaxial instability in mucopolysaccharidosis type VII. J Pediatr Orthop 1989;9:76–78

    CrossRefPubMed
65. 65.↵
    1. Hite SH,
    2. Krivit W,
    3. Haines SJ,
    4. et al

    . Syringomyelia in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): imaging findings following bone marrow transplantation. Pediatr Radiol 1997;27:736–38

    CrossRefPubMedWeb of Science
66. 66.↵
    1. Samia P,
    2. Wieselthaler N,
    3. van der Watt GF,
    4. et al

    . Hemiatrophy of the spinal cord in a patient with mucopolysaccharidosis type IIIB. J Child Neurol 2010;25:1288–91

    Abstract/FREE Full Text
67. 67.↵
    1. Davison JE,
    2. Hendriksz CJ,
    3. Sun Y,
    4. et al

    . Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome). J Inherit Metab Dis 2010 Oct 1. [Epub ahead of print].
68. 68.↵
    1. Vedolin L,
    2. Schwartz IV,
    3. Komlos M,
    4. et al

    . Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology 2007;69:917–24

    CrossRef
69. 69.↵
    1. Segawa F,
    2. Kishibayashi J,
    3. Kamada K,
    4. et al

    . Diffusion anisotropy in cerebral white matter lesion [in Japanese]. No To Shinkei 1994;46:765–70

    PubMed
70. 70.↵
    1. Sener RN

    . Diffusion magnetic resonance imaging patterns in metabolic and toxic brain disorders. Acta Radiol 2004;45:561–70

    FREE Full Text
71. 71.↵
    1. Hite SH,
    2. Peters C,
    3. Krivit W

    . Correction of odontoid dysplasia following bone marrow transplantation and engraftment (in Hurler syndrome MPS 1H). Pediatr Radiol 2000;30:464–70

    CrossRefPubMedWeb of Science
72. 72.↵
    1. Wang RY,
    2. Cambray-Forker EJ,
    3. Ohanian K,
    4. et al

    . Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II. Mol Genet Metab 2009;98:406–11

    CrossRefPubMedWeb of Science
73. 73.↵
    1. Munoz-Rojas MV,
    2. Vieira T,
    3. Costa R,
    4. et al

    . Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. Am J Med Genet A 2008;146A:2538–44

    CrossRefPubMed
74. 74.↵
    1. Muñoz-Rojas MV,
    2. Horovitz DD,
    3. Jardim LB,
    4. et al

    . Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis. Mol Genet Metab 2010;99:346–50

    CrossRefPubMedWeb of Science